Literature DB >> 25744273

The vulnerable patient with chronic kidney disease.

Georg Schlieper1, Katharina Hess2, Jürgen Floege1, Nikolaus Marx2.   

Abstract

Patients with chronic kidney disease (CKD) exhibit an increased cardiovascular risk. The high susceptibility to cardiovascular disease renders CKD patients 'vulnerable patients'. The overall cardiovascular risk of a vulnerable patient with CKD is determined by the components of the vulnerable myocardium, the vulnerable vessel and the vulnerable blood which in sum contribute to the increased morbidity and mortality risk in CKD patients. Future therapeutic strategies to reduce cardiovascular morbidity and mortality in this high-risk population should address all three aspects of vulnerability in CKD patients.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25744273     DOI: 10.1093/ndt/gfv041

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Challenging the use of warfarin in patients on dialysis with atrial fibrillation.

Authors:  Georg Schlieper; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

Review 2.  [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Authors:  G Schlieper; V Schwenger; A Remppis; T Keller; R Dechend; S Massberg; S Baldus; T Weinreich; G Hetzel; J Floege; F Mahfoud; D Fliser
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

3.  Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis.

Authors:  Katharina Schuett; Anna Savvaidis; Sebastian Maxeiner; Katharina Lysaja; Vera Jankowski; Stephan H Schirmer; Nada Dimkovic; Peter Boor; Nadine Kaesler; Friedo W Dekker; Jürgen Floege; Nikolaus Marx; Georg Schlieper
Journal:  J Am Soc Nephrol       Date:  2017-01-05       Impact factor: 10.121

Review 4.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

5.  Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients.

Authors:  Giuseppe Cianciolo; Irene Capelli; Maria Cappuccilli; Roberto Schillaci; Mario Cozzolino; Gaetano La Manna
Journal:  Clin Kidney J       Date:  2016-01-18

6.  A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.

Authors:  Marieke Sternkopf; Sven Thoröe-Boveleth; Tobias Beck; Kirsten Oleschko; Ansgar Erlenkötter; Ulrich Tschulena; Sonja Steppan; Thimoteus Speer; Claudia Goettsch; Vera Jankowski; Joachim Jankowski; Heidi Noels
Journal:  Toxins (Basel)       Date:  2019-07-03       Impact factor: 4.546

7.  Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.

Authors:  Savas Ozturk; Kenan Turgutalp; Mustafa Arici; Ali Riza Odabas; Mehmet Riza Altiparmak; Zeki Aydin; Egemen Cebeci; Taner Basturk; Zeki Soypacaci; Garip Sahin; Tuba Elif Ozler; Ekrem Kara; Hamad Dheir; Necmi Eren; Gultekin Suleymanlar; Mahmud Islam; Melike Betul Ogutmen; Erkan Sengul; Yavuz Ayar; Murside Esra Dolarslan; Serkan Bakirdogen; Seda Safak; Ozkan Gungor; Idris Sahin; Ilay Berke Mentese; Ozgur Merhametsiz; Ebru Gok Oguz; Dilek Gibyeli Genek; Nadir Alpay; Nimet Aktas; Murat Duranay; Selma Alagoz; Hulya Colak; Zelal Adibelli; Irem Pembegul; Ender Hur; Alper Azak; Dilek Guven Taymez; Erhan Tatar; Rumeyza Kazancioglu; Aysegul Oruc; Enver Yuksel; Engin Onan; Kultigin Turkmen; Nuri Baris Hasbal; Ali Gurel; Berna Yelken; Tuncay Sahutoglu; Mahmut Gok; Nurhan Seyahi; Mustafa Sevinc; Sultan Ozkurt; Savas Sipahi; Sibel Gokcay Bek; Feyza Bora; Bulent Demirelli; Ozgur Akin Oto; Orcun Altunoren; Serhan Zubeyde Tuglular; Mehmet Emin Demir; Mehmet Deniz Ayli; Bulent Huddam; Mehmet Tanrisev; Ilter Bozaci; Meltem Gursu; Betul Bakar; Bulent Tokgoz; Halil Zeki Tonbul; Alaattin Yildiz; Siren Sezer; Kenan Ates
Journal:  Nephrol Dial Transplant       Date:  2020-12-04       Impact factor: 5.992

8.  Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies.

Authors:  Javier Roberti; Amanda Cummings; Michelle Myall; Jonathan Harvey; Kate Lippiett; Katherine Hunt; Federico Cicora; Juan Pedro Alonso; Carl R May
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692

Review 9.  Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities.

Authors:  Anika Himmelsbach; Carina Ciliox; Claudia Goettsch
Journal:  Toxins (Basel)       Date:  2020-03-14       Impact factor: 4.546

10.  Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling.

Authors:  Zhongping Su; Pengyu Zong; Ji Chen; Shuo Yang; Yihui Shen; Yan Lu; Chuanxi Yang; Xiangqing Kong; Yanhui Sheng; Wei Sun
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.